Current financial headlines

Sharemaestro Newsreel

Financial news from across the world, newest first. Choose a country or market group, open the source, or continue into the company data.

Showing
2341–2376
Headlines
2390
Sources here
17
Companies here
9
Current section United States Drug Manufacturers - General news

Chronological news

Earlier headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Novo Nordisk A/S (NVO) draws heavier tape as 12-week rebound reaches 30.0%

The healthcare heavyweight is recovering in weekly context, but Relative Strength remains negative and the trend signal has not reactivated.

NVO main company
Sharemaestro market context Trend signal started 52 weeks -16.7% NVO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Merck’s 13% week outruns drugmaker breadth and lands within 0.1% of its yearly high

MRK closed at $128.70 after a high-range advance on 64.4M shares, with the weekly Trend Signal still active but Market Dynamics short of a fresh buy confirmation.

MRK main company
Sharemaestro market context Trend signal active 52 weeks +60.7% MRK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Johnson & Johnson’s 54.9M-share high tests the limit of an unconfirmed advance

JNJ jumped 11.5% to finish just 0.2% below its 52-week high, but negative activity pressure and a 52% Fair Value premium keep the weekly setup from being one-sided.

JNJ main company
Sharemaestro market context Trend signal active 52 weeks +48.8% JNJ stored weekly price path from 22 Aug 2025 to 14 Aug 2026

AbbVie Inc (ABBV) gets a 17.0% weekly reset on heavy turnover

The healthcare heavyweight’s latest weekly move sharpened a broader four-week advance, though the trend signal has not yet turned active.

ABBV main company
Sharemaestro market context Trend signal active 52 weeks +21.3% · Next-week setup positive 57.6% ABBV stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Johnson & Johnson (JNJ) insider filing adds an executive acquisition

The update gives investors a fresh ownership datapoint as the drugmaker is viewed through weekly market data rather than live intraday action.

JNJ main company
Sharemaestro market context Trend signal active 52 weeks +48.8% JNJ stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Novartis AG ADR (NVS) preferred-stock disposal record meets firmer weekly tape

The insider-activity item is historical, while current market data show the healthcare ADR rising across recent weekly horizons with some pressure still present.

NVS main company
Sharemaestro market context Trend signal active 52 weeks +22.5% · Next-week setup positive 61.2% NVS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Scilex Holding Company (“Scilex”) Confirms the Previously Announced Payment Date of June 15, 2026 for the Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities

SCLX main company
Sharemaestro market context Trend signal active 52 weeks -42.5% · Next-week setup negative 43.9% SCLX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Datavault AI Announces Execution of Binding Term Sheet for $120 Million Cash Contribution From Scilex Holding Company to Fund 100-City GPU Expansion of Quantum-Ready SanQtum Platform

SCLX main company
Sharemaestro market context Trend signal active 52 weeks -42.5% · Next-week setup negative 43.9% SCLX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context